Theravance Biopharma Inc. appointed Laurie Alsup as an independent director.
Alsup is the COO and chief scientific officer of NDA Group.
Theravance Biopharma adds independent director
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Theravance Biopharma adds independent director
- Author Kshitiz Goliya
- Theme Healthcare & Pharmaceuticals
- Author
- Kshitiz Goliya
- Theme
- Healthcare & Pharmaceuticals